Ajanta Pharma Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic areas comprising cardiology, dermatology, ophthalmology, and pain management. The company operates in India, Africa, Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.
Metrics to compare | AJPH | Peers Peers - average of corresponding metrics from companies closely matching AJPH: JBCHEPHARM, LAURUSLABS, GLAND, 524731, GLENMARK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAJPHPeersSector |
---|---|---|---|---|
P/E Ratio | 36.2x | 35.4x | −0.5x | |
PEG Ratio | 3.69 | 0.33 | 0.00 | |
Price/Book | 8.9x | 5.3x | 2.6x | |
Price / LTM Sales | 7.0x | 5.1x | 3.3x | |
Upside (Analyst Target) | 17.7% | 3.6% | 45.1% | |
Fair Value Upside | Unlock | −6.5% | 7.4% | Unlock |